KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $238.0 million.

  • Merck's Other Non Operating Income rose 4691.36% to $238.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $153.0 million, marking a year-over-year increase of 10400.0%. This contributed to the annual value of $24.0 million for FY2024, which is 10515.02% up from last year.
  • As of Q3 2025, Merck's Other Non Operating Income stood at $238.0 million, which was up 4691.36% from $7.0 million recorded in Q2 2025.
  • In the past 5 years, Merck's Other Non Operating Income registered a high of $455.0 million during Q1 2021, and its lowest value of -$708.0 million during Q1 2022.
  • For the 5-year period, Merck's Other Non Operating Income averaged around -$16.7 million, with its median value being $7.0 million (2025).
  • Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 74084.51% in 2021, then tumbled by 52524.27% in 2022.
  • Over the past 5 years, Merck's Other Non Operating Income (Quarter) stood at $334.0 million in 2021, then plummeted by 77.54% to $75.0 million in 2022, then crashed by 204.0% to -$78.0 million in 2023, then plummeted by 62.82% to -$127.0 million in 2024, then soared by 287.4% to $238.0 million in 2025.
  • Its Other Non Operating Income stands at $238.0 million for Q3 2025, versus $7.0 million for Q2 2025 and $35.0 million for Q1 2025.